Clinical Considerations for Cannabis Use and Cardiovascular Health

Med Cannabis Cannabinoids. 2022 Sep 28;5(1):120-127. doi: 10.1159/000526731. eCollection 2022 Jan-Dec.

Ruba Sajdeya^{1

2}, Sebastian Jugl^{1

3}, Robert Cook^{1

2}, Joshua D Brown^{1

3}, Amie Goodin^{1

3}

¹ Consortium for Medical Marijuana Clinical Outcomes Research, University of Florida, Gainesville, Florida, USA.
² Department of Epidemiology, University of Florida, Gainesville, Florida, USA.
³ Center for Drug Evaluation and Safety (CoDES), Department of Pharmaceutical Outcomes & Policy, University of Florida, Gainesville, Florida, USA.

No abstract available

Keywords: Cannabinoids; Cannabis; Cardiovascular effects; Drug-drug interactions; Major adverse cardiovascular events; Marijuana.

Grants and funding

The authors are supported by State of Florida appropriations to the Consortium for Medical Marijuana Clinical Outcomes Research (mmjoutcomes.org).